Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33
United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Adam M Veness
13 Aug 2026
SVP, General Counsel and Sec.
Exercised, kept
15,000
$18.17
$272.55K
Marino Garcia
16 Mar 2026
CEO and President
Exercised, kept
5,592
$17.88
$99.98K
Marino Garcia
16 Mar 2026
CEO and President
Exercised, kept
59,700
$6.70
$399.99K

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 71
Sales at will 37
Transactions with no price 0
Shares from compensation/vesting 32,438,229
Sales filed before the plan box existed 37
History held since 27 Jun 2018